Tag: Depresija
-

New brain-mapping study suggests psychedelics mute visual reality and amplify memory signals
A new imaging study maps how psychedelics may suppress visual input and strengthen memory-driven brain signals, offering clues to hallucinations and therapy…
-

Vagus nerve stimulation implant shows lasting gains for treatment-resistant depression, and some patients reach remission
A large U.S. RECOVER trial suggests a vagus nerve stimulation implant can deliver lasting improvements in treatment-resistant depression, with some patients in…
-

Why US Midlife Is Getting Harder: Rising Loneliness, Memory Decline, and a Weaker Safety Net
New cross-country research suggests US midlife is becoming a breaking point, with higher loneliness and memory decline tied to weaker family supports and…
-
Precision Treatment for Depression: A New Data-Driven Model Aims to Match Patients With the Therapy Most Likely to Work
Researchers are moving beyond trial-and-error care for depression with a precision approach designed to better match patients to treatments based on individual…
-

Late-life depression could precede Parkinson’s or Lewy body dementia, Danish study suggests
A Danish registry study suggests late-life depression may precede Parkinson’s disease or Lewy body dementia, supporting closer screening and follow-up.
-

Teen Diet and Depression Risk: A Major Review Points to Whole Foods Over Supplements
A Swansea-led review finds healthier teen diets are more consistently linked to fewer depressive symptoms than supplements, but researchers say key gaps remain.
-

Exercise emerges as a leading option for depression and anxiety, with group programs showing the biggest gains
A wide-ranging evidence review suggests structured exercise can ease depression and anxiety, with supervised or group programs often delivering the strongest…
-

Major Lancet review questions medicinal cannabis for anxiety and PTSD as trial evidence falls short
A major Lancet review finds medicinal cannabis lacks solid evidence for anxiety, depression or PTSD, urging caution as use grows and safety risks persist.
-

Ozempic and other GLP-1 drugs linked to lower depression and addiction risk in large Swedish study
A large Swedish registry study links GLP-1 drugs like Ozempic with lower rates of depression, anxiety and substance use-related care, though causation remains…
-

Ozempic and other GLP-1 drugs tied to lower depression and anxiety in large Swedish study, raising new questions about mental health benefits
A Swedish registry study suggests Ozempic and other GLP-1 drugs are linked to fewer depression and anxiety diagnoses, but researchers say causality is unproven.